Activation of systemic Tregs with an increase of CTLA‐4 expression was confirmed after treatment with ICI followed by disease progression, suggesting that the CTLA‐4 signaling pathway could be one of the key mechanisms of acquired resistance to PD‐1/PD‐L1 blockade therapy in carcinoid. This evidence concerns the gene CD274 and carcinoid tumor.